Cardiovascular magnetic resonance imaging as applied to patients with pulmonary arterial hypertension

International Journal of Clinical Practice

Volumn 63, Issue SUPPL. 162, 2009, Pages 20-35

  Biederman, R W W ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; GADOBENATE DIMEGLUMINE; GADOLINIUM; LORAZEPAM; PRISTANE; PROSTACYCLIN; RADIOISOTOPE; VASODILATOR AGENT;

ANALYTIC METHOD; ATRIOVENTRICULAR BLOCK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PROCEDURES; CLAUSTROPHOBIA; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ENDARTERECTOMY; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE PERFUSION; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE SEPTUM DEFECT; HUMAN; IMAGE ENHANCEMENT; INVASIVE PROCEDURE; LUNG CIRCULATION; LUNG TRANSPLANTATION; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT MONITORING; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY STENOSIS; PULMONARY ENDARTERECTOMY; PULMONARY HYPERTENSION; RADIATION SAFETY; REVIEW; SIGNAL NOISE RATIO; SURGICAL TECHNIQUE; SYSTEMIC SCLEROSIS; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TISSUE DOPPLER IMAGING; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 68349098972     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02109.x     Document Type: Review

References (67)

1. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004 351 : 1425 36.
2. Simonneau G, Galie N, Rubin LJ et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004 43 : 5S 12S.
3. McGoon M, Gutterman D, Steen V et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004 126 : 14S 34S.
4. D'Alonzo GE, Barst RJ, Ayres SM et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991 115 : 343 9.
5. van Wolferen SA, Marcus JT, Boonstra A et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007 28 : 1250 7.
6. Grigioni F, Potena L, Galie N et al. Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. J Heart Lung Transplant 2006 25 : 1241 6.
7. Mahapatra S, Nishimura RA, Sorajja P et al. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 2006 47 : 799 803.
8. Galie N, Torbicki A, Barst R et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004 25 : 2243 78.
9. Hoffmann R, Hanrath P. Tricuspid annular velocity measurement. Simple and accurate solution for a delicate problem? Eur Heart J 2001 22 : 280 2.
10. Ueti OM, Camargo EE, Ueti Ade A et al. Assessment of right ventricular function with Doppler echocardiographic indices derived from tricuspid annular motion: comparison with radionuclide angiography. Heart 2002 88 : 244 8.
11. Marcu CB, Beek AM, Van Rossum AC. Cardiovascular magnetic resonance imaging for the assessment of right heart involvement in cardiac and pulmonary disease. Heart Lung Circ 2006 15 : 362 70.
12. Boxt LM. Radiology of the right ventricle. Radiol Clin North Am 1999 37 : 379 400.
13. Dell'Italia LJ, Santamore WP. Can indices of left ventricular function be applied to the right ventricle? Prog Cardiovasc Dis 1998 40 : 309 24.
14. Haber I, Metaxas DN, Axel L. Three-dimensional motion reconstruction and analysis of the right ventricle using tagged CMR. Med Image Anal 2000 4 : 335 55.
15. Haber I, Metaxas DN, Geva T, Axel L. Three-dimensional systolic kinematics of the right ventricle. Am J Physiol Heart Circ Physiol 2005 289 : H1826 33.
16. Bristow MR, Zisman LS, Lowes BD et al. The pressure-overloaded right ventricle in pulmonary hypertension. Chest 1998 114 : 101S 6S.
17. Konstam MA, Cohen SR, Salem DN et al. Comparison of left and right ventricular end-systolic pressure-volume relations in congestive heart failure. J Am Coll Cardiol 1985 5 : 1326 34.
18. Boxt LM, Katz J, Kolb T et al. Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension. J Am Coll Cardiol 1992 19 : 1508 15.
19. Blyth KG, Groenning BA, Martin TN et al. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 2005 26 : 1993 9.
20. Marcu CB, Beek AM, van Rossum AC. Clinical applications of cardiovascular magnetic resonance imaging. CMAJ 2006 175 : 911 7.
21. Laffon E, Vallet C, Bernard V et al. A computed method for noninvasive CMR assessment of pulmonary arterial hypertension. J Appl Physiol 2004 96 : 463 8.
22. Olechewski H. Dana point: what is new in diagnostics of pulmonary hypertension? Dtsch Med Wochenschr 2008 133 (Suppl. 6 S180 2 (Epub 23 September 2008).
23. McLure LER, Peacock AJ. Imaging of the heart in pulmonary hypertension. Int J Clin Pract 2007 61 Suppl. 156 15 26.
24. Benza R, Murali S, Biederman RWW, Gupta H. Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension. J Amer Coll Cardio 2008 52 : 1682 92.
25. Pennell DJ, Sechtem UP, Higgins CB et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 2004 25 : 1940 65.
26. McCann GP, Gan CT, Beek AM et al. Extent of CMR delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension. AJR Am J Roentgenol 2007 188 : 349 55.
27. Sanz J, Dellegrottaglie S, Kariisa M et al. Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Am J Cardiol 2007 100 : 731 5 (Epub 27 June 2007).
28. Kondo C, Caputo GR, Masui T et al. Pulmonary hypertension: pulmonary flow quantification and flow profile analysis with velocity-encoded cine MR imaging. Radiology 1992 183 : 751 8.
29. Frank H, Globits S, Glogar D et al. Detection and quantification of pulmonary artery hypertension with MR imaging: results in 23 patients. AJR Am J Roentgenol 1993 161 : 27 31.
30. Katz J, Whang J, Boxt LM, Barst RJ. Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging. J Am Coll Cardiol 1993 21 : 1475 81.
31. Dellegrottaglie S, Sanz J, Poon M et al. Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology 2007 243 : 63 9.
32. Rathi V, Murali S, Akkineni M et al. Right and left ventricular morphologic and functional differences between patients with severe idiopathic vs. secondary pulmonary hypertension; insights from cardiovascular MRI. J Cardiovasc MRI 2008 8 (Suppl. I 132 3.
33. Zerhouni EA, Parish DM, Rogers WJ et al. Human heart: tagging with MR imaging - a method for noninvasive assessment of myocardial motion. Radiology 1988 169 : 59 63.
34. Biederman RWW, Doyle M, Yamrozik J et al. Physiologic compensation is supranormal in compensated aortic stenosis: does it return to normal after aortic valve replacement or is it blunted by coexistent coronary artery disease? Circulation 2005 112 (Suppl. I I-429 36.
35. Vonk-Noordegraaf A, Marcus JT, Gan CT et al. Interventricular mechanical asynchrony due to right ventricular pressure overload in pulmonary hypertension plays an important role in impaired left ventricular filling. Chest 2005 128 : 628S 30S.
36. Ley S, Mereles D, Puderbach M et al. Value of MR phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension. Eur Radiol 2007 17 : 1892 7.
37. Sridharan S, Derrick G, Deanfield J, Taylor AM. Assessment of differential branch pulmonary blood flow: a comparative study of phase contrast magnetic resonance imaging and radionuclide lung perfusion imaging. Heart 2006 92 : 963 8.
38. Hernández-González MA, Espínola-Zavaleta N, Solorio S et al. Cardiovascular magnetic resonance evaluation of left-to-right shunts due to cardiac septal defects in patients with pulmonary arterial hypertension. Rev Esp Cardiol 2007 60 : 907 13.
39. Saba TS, Foster J, Cockburn M et al. Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure. Eur Respir J 2002 20 : 1519 24.
40. Nikolaou K, Schoenberg SO, Attenberger U et al. Pulmonary arterial hypertension: diagnosis with fast perfusion MR imaging and high-spatial- resolution MR angiography - preliminary experience. Radiology 2005 236 : 694 703.
41. Roeleveld RJ, Marcus JT, Boonstra A et al. A comparison of noninvasive CMR-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging 2005 22 : 67 72.
42. Sanz J, Kuschnir P, Rius T et al. Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology 2007 243 : 70 9.
43. Lederman RJ. Cardiovascular interventional magnetic resonance imaging. Circulation 2005 112 : 3009 17.
44. Kuehne T, Yilmaz S, Steendijk P et al. Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension. Circulation 2004 110 : 2010 6.
45. Iino M, Dymarkowski S, Chaothawee L, Delcroix M, Bogaert J. Time course of reversed cardiac remodeling after pulmonary endarterectomy in patients with chronic pulmonary thromboembolism. Eur Radiol 2008 18 : 792 9 (Epub 20 December 2007).
46. Kuehne T, Yilmaz S, Schulze-Neick I et al. Magnetic resonance imaging guided catheterisation for assessment of pulmonary vascular resistance: in vivo validation and clinical application in patients with pulmonary hypertension. Heart 2005 91 : 1064 9.
47. Costa EL, Jardim C, Bogossian HB et al. Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria. Vascul Pharmacol 2005 43 : 143 7.
48. Jardim C, Rochitte CE, Humbert M et al. Pulmonary artery distensibility in pulmonary arterial hypertension: a CMR pilot study. Eur Respir J 2007 29 : 476 81.
49. Roeleveld RJ, Vonk-Noordegraaf A, Marcus JT et al. Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. Chest 2004 125 : 572 9.
50. Allanore Y, Meune C, Vignaux O et al. Bosentan increases myocardial perfusion and function in systemic sclerosis: a magnetic resonance imaging and Tissue-Doppler echography study. J Rheumatol 2006 33 : 2464 9.
51. Reesink HJ, Marcus JT, Tulevski II et al. Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of magnetic resonance imaging to demonstrate restoration of the right ventricle. J Thorac Cardiovasc Surg 2007 133 : 58 64.
52. Rathi VK, Doyle M, Yamrozik J, Williams R, Rayarao G, Biederman RWW. Routine evaluation of diastolic left ventricular function by CMR; a practical approach. J Cardiovasc Magn Reson 2008 10 : 36.
53. Rathi VK, Doyle M, Yamrozik J et al. 3D diastolic function assessment of the right ventricle: interrogation by cardiovascular MRI. J Cardiovasc Magn Reson 2005 7 : 269.
54. Pohost GM, Biederman RW. The role of cardiac MRI stress testing: 'Make a better mouse trap...'. Circulation 1999 19 : 100.
55. Doyle M, Fuisz A, Kortright E et al. The impact of myocardial flow reserve on the detection of coronary artery disease by perfusion imaging methods: an NHLBI WISE study. J Cardiovasc Magn Reson 2003 5 : 475 85.
56. Sciomer S, Magri D, Badagliacca R. Non-invasive assessment of pulmonary hypertension: Doppler-echocardiography. Pulm Pharmacol Ther 2007 20 : 135 40.
57. Bossone E, Bodini BD, Mazza A, Allegra L. Pulmonary arterial hypertension: the key role of echocardiography. Chest 2005 127 : 1836 43.
58. Borges AC, Knebel F, Eddicks S et al. Right ventricular function assessed by two-dimensional strain and tissue Doppler echocardiography in patients with pulmonary arterial hypertension and effect of vasodilator therapy. Am J Cardiol 2006 98 : 530 4.
59. Gopal AS, Chukwu EO, Mihalatos DG et al. Left ventricular structure and function for postmyocardial infarction and heart failure risk stratification by three-dimensional echocardiography. J Am Soc Echocardiogr 2007 20 : 949 58.
60. Kjaergaard J, Sogaard P, Hassager C. Quantitative echocardiographic analysis of the right ventricle in healthy individuals. J Am Soc Echocardiogr 2006 19 : 1365 72.
61. Heatlie G, Pennell DJ. Cardiovascular magnetic resonance at 0.5 T in five patients with permanent pacemakers. J Cardiovasc Magn Reson 2007 9 : 15 9.
62. Martin ET, Coman JA, Shellock FG et al. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004 43 : 1315 24.
63. Biederman RWW, Yamrozik J, Doyle M. Foreword by Valentine Fuster. Cardiovascular Magnetic Resonance Imaging Tutorial: Lectures and Learning. Lippincott, Williams and Wilkins, 2007.
64. Rehwald WG, Wagner A, Sievers B et al. Cardiovascular CMR: its current and future use in clinical practice. Expert Rev Cardiovasc Ther 2007 5 : 307 21.
65. Lima JA, Desai MY. Cardiovascular magnetic resonance imaging: current and emerging applications. J Am Coll Cardiol 2004 44 : 1164 71.
66. Sallach SM, Peshock RM, Reimold S. Noninvasive cardiac imaging in pulmonary hypertension. Cardiol Rev 2007 15 : 97 101.
67. Doyle M, Biederman RW. Future prospects in magnetic resonance imaging. Curr Cardiol Rep 2004 6 : 70 5.